Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. Drug (Description in trials) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY Disease ID
1Administration of Methylprednisolone + Prednisone + Mycophenolate mofetil
(Synonym: Depo-medrol (TN))		[4] Methylprednisolone (Synonym: Depo-medrol With Lidocaine),
Mycophenolate mofetil,
Mycophenolic acid,
Prednisone		[11] D00407 (Name: Medrol (TN)),
D00473 ,
D00751 (Name: Solu-medrol (TN)),
D00752 ,
D00979 (Name: Depo-medrol (TN)),
D05000 ,
D05001 ,
D05002 ,
D05094 ,
D05095 ,
D05096 		[3] IMPDH1,
IMPDH2,
NR3C1 💬		[4] Drug metabolism - other enzymes, Metabolic pathways, Neuroactive ligand-receptor interaction, Purine metabolism 💬[1] 49
2Administration of methylprednisolone, paracetamol and dexchlorpheniramine
(Synonym: Depo-medrol (TN))		[3] Acetaminophen,
Dexchlorpheniramine,
Methylprednisolone (Synonym: Depo-medrol With Lidocaine)		[8] D00217 ,
D00407 (Name: Medrol (TN)),
D00751 (Name: Solu-medrol (TN)),
D00979 (Name: Depo-medrol (TN)),
D05000 ,
D05001 ,
D05002 ,
D07803 		[4] HRH1,
NR3C1,
PTGS1,
PTGS2 💬		[26] Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Calcium signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Inflammatory mediator regulation of TRP channels, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Neuroactive ligand-receptor interaction, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬[1] 49
3Administration of rituximab and methylprednisolone
(Synonym: Depo-medrol (TN))		[2] Methylprednisolone (Synonym: Depo-medrol With Lidocaine),
Rituximab		[7] D00407 (Name: Medrol (TN)),
D00751 (Name: Solu-medrol (TN)),
D00979 (Name: Depo-medrol (TN)),
D02994 ,
D05000 ,
D05001 ,
D05002 		[2] MS4A1,
NR3C1 💬		[2] Hematopoietic cell lineage, Neuroactive ligand-receptor interaction 💬[1] 51
4Corticosteroid treatment (Methylprednisolone or prednisolone)
(Synonym: Depo-medrol (TN))		[2] Methylprednisolone (Synonym: Depo-medrol With Lidocaine),
Prednisolone		[14] D00407 (Name: Medrol (TN)),
D00472 ,
D00751 (Name: Solu-medrol (TN)),
D00979 (Name: Depo-medrol (TN)),
D00980 ,
D00981 ,
D00982 ,
D01239 ,
D01998 ,
D02156 ,
D03301 ,
D05000 ,
D05001 ,
D05002 		[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 64
5Cyclophosphamide, Azathioprine,prednisone,methylprednisolone
(Synonym: Depo-medrol (TN))		[4] Azathioprine,
Cyclophosphamide,
Methylprednisolone (Synonym: Depo-medrol With Lidocaine),
Prednisone		[11] D00238 ,
D00287 ,
D00407 (Name: Medrol (TN)),
D00473 ,
D00751 (Name: Solu-medrol (TN)),
D00979 (Name: Depo-medrol (TN)),
D03033 ,
D05000 ,
D05001 ,
D05002 ,
D07760 		[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[3] 42, 43, 45
6Depo Medrol----[1] 46
7Infliximab, methylprednisolone, methotrexate
(Synonym: Depo-medrol (TN))		[3] Infliximab,
Methotrexate,
Methylprednisolone (Synonym: Depo-medrol With Lidocaine)		[9] D00142 ,
D00407 (Name: Medrol (TN)),
D00751 (Name: Solu-medrol (TN)),
D00979 (Name: Depo-medrol (TN)),
D02115 ,
D02598 ,
D05000 ,
D05001 ,
D05002 		[4] DHFR,
DHFR2,
NR3C1,
TNF 💬		[72] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, Biosynthesis of cofactors, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Folate biosynthesis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Metabolic pathways, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Neuroactive ligand-receptor interaction, Non-alcoholic fatty liver disease, One carbon pool by folate, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬[1] 46
8Interferon-beta-1a (Avonex) plus methylprednisolone
(Synonym: Depo-medrol (TN))		[3] Human interferon beta,
Interferon beta-1a,
Methylprednisolone (Synonym: Depo-medrol With Lidocaine)		[7] D00407 (Name: Medrol (TN)),
D00751 (Name: Solu-medrol (TN)),
D00979 (Name: Depo-medrol (TN)),
D04554 ,
D05000 ,
D05001 ,
D05002 		[3] IFNAR1,
IFNAR2,
NR3C1 💬		[19] Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Neuroactive ligand-receptor interaction, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬[1] 13
9Intravenous (i.v.) methylprednisolone 1000 mg, total 9
(Synonym: Depo-medrol (TN))		[1] Methylprednisolone (Synonym: Depo-medrol With Lidocaine)[6] D00407 (Name: Medrol (TN)),
D00751 (Name: Solu-medrol (TN)),
D00979 (Name: Depo-medrol (TN)),
D05000 ,
D05001 ,
D05002 		[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 222
10Intravenous Methylprednisolone
(Synonym: Depo-medrol (TN))		[1] Methylprednisolone (Synonym: Depo-medrol With Lidocaine)[6] D00407 (Name: Medrol (TN)),
D00751 (Name: Solu-medrol (TN)),
D00979 (Name: Depo-medrol (TN)),
D05000 ,
D05001 ,
D05002 		[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[2] 13, 145
11IV methylprednisolone
(Synonym: Depo-medrol (TN))		[1] Methylprednisolone (Synonym: Depo-medrol With Lidocaine)[6] D00407 (Name: Medrol (TN)),
D00751 (Name: Solu-medrol (TN)),
D00979 (Name: Depo-medrol (TN)),
D05000 ,
D05001 ,
D05002 		[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 13
12IV methylprednisolone (steroids)
(Synonym: Depo-medrol (TN))		[1] Methylprednisolone (Synonym: Depo-medrol With Lidocaine)[6] D00407 (Name: Medrol (TN)),
D00751 (Name: Solu-medrol (TN)),
D00979 (Name: Depo-medrol (TN)),
D05000 ,
D05001 ,
D05002 		[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 13
13Medrol----[4] 13, 46, 56, 222
14MEDROL - 4 MG COMPRESSE 30 COMPRESSE----[1] 56
15Medrol 4 mg tablets[1] Methylprednisolone (Synonym: Depo-medrol With Lidocaine)[6] D00407 (Name: Medrol (TN)),
D00751 (Name: Solu-medrol (TN)),
D00979 (Name: Depo-medrol (TN)),
D05000 ,
D05001 ,
D05002 		[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 46
16Medrol A 16 mg tablets[1] Methylprednisolone (Synonym: Depo-medrol With Lidocaine)[6] D00407 (Name: Medrol (TN)),
D00751 (Name: Solu-medrol (TN)),
D00979 (Name: Depo-medrol (TN)),
D05000 ,
D05001 ,
D05002 		[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 46
17MEDROL*10CPR DIV 4MG[1] Methylprednisolone (Synonym: Depo-medrol With Lidocaine)[6] D00407 (Name: Medrol (TN)),
D00751 (Name: Solu-medrol (TN)),
D00979 (Name: Depo-medrol (TN)),
D05000 ,
D05001 ,
D05002 		[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 222
18Megadose oral methylprednisolone
(Synonym: Depo-medrol (TN))		[1] Methylprednisolone (Synonym: Depo-medrol With Lidocaine)[6] D00407 (Name: Medrol (TN)),
D00751 (Name: Solu-medrol (TN)),
D00979 (Name: Depo-medrol (TN)),
D05000 ,
D05001 ,
D05002 		[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 13
19Methotrexate + Methylprednisolone
(Synonym: Depo-medrol (TN))		[2] Methotrexate,
Methylprednisolone (Synonym: Depo-medrol With Lidocaine)		[8] D00142 ,
D00407 (Name: Medrol (TN)),
D00751 (Name: Solu-medrol (TN)),
D00979 (Name: Depo-medrol (TN)),
D02115 ,
D05000 ,
D05001 ,
D05002 		[3] DHFR,
DHFR2,
NR3C1 💬		[6] Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, Neuroactive ligand-receptor interaction, One carbon pool by folate 💬[1] 46
20Methylprednisolon (Solu-Medrol)[1] Methylprednisolone (Synonym: Depo-medrol With Lidocaine)[6] D00407 (Name: Medrol (TN)),
D00751 (Name: Solu-medrol (TN)),
D00979 (Name: Depo-medrol (TN)),
D05000 ,
D05001 ,
D05002 		[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 14
21Methylprednisolone
(Synonym: Depo-medrol (TN))		[1] Methylprednisolone (Synonym: Depo-medrol With Lidocaine)[6] D00407 (Name: Medrol (TN)),
D00751 (Name: Solu-medrol (TN)),
D00979 (Name: Depo-medrol (TN)),
D05000 ,
D05001 ,
D05002 		[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[48] 2, 6, 11, 13, 14, 18, 19, 25, 26, 35, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 51, 60, 62, 63, 64, 65, 66, 83, 84, 86, 93, 95, 96, 97, 127, 145, 162, 164, 211, 220, 222, 224, 271, 283, 284, 285, 296, 300
22Methylprednisolone (drug)
(Synonym: Depo-medrol (TN))		[1] Methylprednisolone (Synonym: Depo-medrol With Lidocaine)[6] D00407 (Name: Medrol (TN)),
D00751 (Name: Solu-medrol (TN)),
D00979 (Name: Depo-medrol (TN)),
D05000 ,
D05001 ,
D05002 		[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 13
23Methylprednisolone (MP)
(Synonym: Depo-medrol (TN))		[1] Methylprednisolone (Synonym: Depo-medrol With Lidocaine)[6] D00407 (Name: Medrol (TN)),
D00751 (Name: Solu-medrol (TN)),
D00979 (Name: Depo-medrol (TN)),
D05000 ,
D05001 ,
D05002 		[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[2] 60, 285
24Methylprednisolone (MP) or prednisone (pred)
(Synonym: Depo-medrol (TN))		[2] Methylprednisolone (Synonym: Depo-medrol With Lidocaine),
Prednisone		[7] D00407 (Name: Medrol (TN)),
D00473 ,
D00751 (Name: Solu-medrol (TN)),
D00979 (Name: Depo-medrol (TN)),
D05000 ,
D05001 ,
D05002 		[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 66
25Methylprednisolone (or other glucocorticoid)
(Synonym: Depo-medrol (TN))		[1] Methylprednisolone (Synonym: Depo-medrol With Lidocaine)[6] D00407 (Name: Medrol (TN)),
D00751 (Name: Solu-medrol (TN)),
D00979 (Name: Depo-medrol (TN)),
D05000 ,
D05001 ,
D05002 		[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 43
26Methylprednisolone (Solu-Medrol)[1] Methylprednisolone (Synonym: Depo-medrol With Lidocaine)[6] D00407 (Name: Medrol (TN)),
D00751 (Name: Solu-medrol (TN)),
D00979 (Name: Depo-medrol (TN)),
D05000 ,
D05001 ,
D05002 		[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 14
27Methylprednisolone 1250 mg/24h x3 days
(Synonym: Depo-medrol (TN))		[1] Methylprednisolone (Synonym: Depo-medrol With Lidocaine)[6] D00407 (Name: Medrol (TN)),
D00751 (Name: Solu-medrol (TN)),
D00979 (Name: Depo-medrol (TN)),
D05000 ,
D05001 ,
D05002 		[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 13
28METHYLPREDNISOLONE ACETATE
(Synonym: Depo-medrol (TN))		[2] Acetate,
Methylprednisolone (Synonym: Depo-medrol With Lidocaine)		[6] D00407 (Name: Medrol (TN)),
D00751 (Name: Solu-medrol (TN)),
D00979 (Name: Depo-medrol (TN)),
D05000 ,
D05001 ,
D05002 		[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[2] 46, 51
29Methylprednisolone and azathioprine
(Synonym: Depo-medrol (TN))		[2] Azathioprine,
Methylprednisolone (Synonym: Depo-medrol With Lidocaine)		[8] D00238 ,
D00407 (Name: Medrol (TN)),
D00751 (Name: Solu-medrol (TN)),
D00979 (Name: Depo-medrol (TN)),
D03033 ,
D05000 ,
D05001 ,
D05002 		[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[2] 93, 95
30Methylprednisolone and Mycophenolate mofetil
(Synonym: Depo-medrol (TN))		[3] Methylprednisolone (Synonym: Depo-medrol With Lidocaine),
Mycophenolate mofetil,
Mycophenolic acid		[10] D00407 (Name: Medrol (TN)),
D00751 (Name: Solu-medrol (TN)),
D00752 ,
D00979 (Name: Depo-medrol (TN)),
D05000 ,
D05001 ,
D05002 ,
D05094 ,
D05095 ,
D05096 		[3] IMPDH1,
IMPDH2,
NR3C1 💬		[4] Drug metabolism - other enzymes, Metabolic pathways, Neuroactive ligand-receptor interaction, Purine metabolism 💬[2] 93, 95
31Methylprednisolone bolus IV 15 mg/kg/d for 3 days.
(Synonym: Depo-medrol (TN))		[1] Methylprednisolone (Synonym: Depo-medrol With Lidocaine)[6] D00407 (Name: Medrol (TN)),
D00751 (Name: Solu-medrol (TN)),
D00979 (Name: Depo-medrol (TN)),
D05000 ,
D05001 ,
D05002 		[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 84
32Methylprednisolone hemisuccinate
(Synonym: Depo-medrol (TN))		[2] Methylprednisolone (Synonym: Depo-medrol With Lidocaine),
Methylprednisolone hemisuccinate (Synonym: Solu-medrol Methylprednisolone Sodium Succinat)		[6] D00407 (Name: Medrol (TN)),
D00751 (Name: Solu-medrol (TN)),
D00979 (Name: Depo-medrol (TN)),
D05000 ,
D05001 ,
D05002 		[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 13
33Methylprednisolone IV
(Synonym: Depo-medrol (TN))		[1] Methylprednisolone (Synonym: Depo-medrol With Lidocaine)[6] D00407 (Name: Medrol (TN)),
D00751 (Name: Solu-medrol (TN)),
D00979 (Name: Depo-medrol (TN)),
D05000 ,
D05001 ,
D05002 		[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 13
34METHYLPREDNISOLONE MYLAN Générique
(Synonym: Depo-medrol (TN))		[1] Methylprednisolone (Synonym: Depo-medrol With Lidocaine)[6] D00407 (Name: Medrol (TN)),
D00751 (Name: Solu-medrol (TN)),
D00979 (Name: Depo-medrol (TN)),
D05000 ,
D05001 ,
D05002 		[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 66
35Methylprednisolone or budesonide
(Synonym: Depo-medrol (TN))		[2] Budesonide,
Methylprednisolone (Synonym: Depo-medrol With Lidocaine)		[7] D00246 ,
D00407 (Name: Medrol (TN)),
D00751 (Name: Solu-medrol (TN)),
D00979 (Name: Depo-medrol (TN)),
D05000 ,
D05001 ,
D05002 		[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 96
36Methylprednisolone or Prednisolone
(Synonym: Depo-medrol (TN))		[2] Methylprednisolone (Synonym: Depo-medrol With Lidocaine),
Prednisolone		[14] D00407 (Name: Medrol (TN)),
D00472 ,
D00751 (Name: Solu-medrol (TN)),
D00979 (Name: Depo-medrol (TN)),
D00980 ,
D00981 ,
D00982 ,
D01239 ,
D01998 ,
D02156 ,
D03301 ,
D05000 ,
D05001 ,
D05002 		[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 65
37Methylprednisolone PO
(Synonym: Depo-medrol (TN))		[1] Methylprednisolone (Synonym: Depo-medrol With Lidocaine)[6] D00407 (Name: Medrol (TN)),
D00751 (Name: Solu-medrol (TN)),
D00979 (Name: Depo-medrol (TN)),
D05000 ,
D05001 ,
D05002 		[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 13
38Methylprednisolone pulse
(Synonym: Depo-medrol (TN))		[1] Methylprednisolone (Synonym: Depo-medrol With Lidocaine)[6] D00407 (Name: Medrol (TN)),
D00751 (Name: Solu-medrol (TN)),
D00979 (Name: Depo-medrol (TN)),
D05000 ,
D05001 ,
D05002 		[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[2] 66, 220
39METHYLPREDNISOLONE SODIUM HEMISUCCINATE
(Synonym: Depo-medrol (TN))		[1] Methylprednisolone (Synonym: Depo-medrol With Lidocaine)[6] D00407 (Name: Medrol (TN)),
D00751 (Name: Solu-medrol (TN)),
D00979 (Name: Depo-medrol (TN)),
D05000 ,
D05001 ,
D05002 		[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[2] 13, 97
40METHYLPREDNISOLONE SODIUM SUCCINATE
(Synonym: Depo-medrol (TN))		[1] Methylprednisolone (Synonym: Depo-medrol With Lidocaine)[6] D00407 (Name: Medrol (TN)),
D00751 (Name: Solu-medrol (TN)),
D00979 (Name: Depo-medrol (TN)),
D05000 ,
D05001 ,
D05002 		[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[6] 13, 46, 49, 50, 51, 211
41Methylprednisolone succinate
(Synonym: Depo-medrol (TN))		[2] Methylprednisolone (Synonym: Depo-medrol With Lidocaine),
Methylprednisolone hemisuccinate (Synonym: Solu-medrol Methylprednisolone Sodium Succinat)		[6] D00407 (Name: Medrol (TN)),
D00751 (Name: Solu-medrol (TN)),
D00979 (Name: Depo-medrol (TN)),
D05000 ,
D05001 ,
D05002 		[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 13
42Methylprednisolone(intravenously in the 1st-2nd-3rd month )
(Synonym: Depo-medrol (TN))		[1] Methylprednisolone (Synonym: Depo-medrol With Lidocaine)[6] D00407 (Name: Medrol (TN)),
D00751 (Name: Solu-medrol (TN)),
D00979 (Name: Depo-medrol (TN)),
D05000 ,
D05001 ,
D05002 		[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 66
43Methylprednisolone(intravenously in the 1st-3rd-5th month)
(Synonym: Depo-medrol (TN))		[1] Methylprednisolone (Synonym: Depo-medrol With Lidocaine)[6] D00407 (Name: Medrol (TN)),
D00751 (Name: Solu-medrol (TN)),
D00979 (Name: Depo-medrol (TN)),
D05000 ,
D05001 ,
D05002 		[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 66
44Oral 5-ASA+/-topical 5-ASA+IV corticosteroids / PO Methylprednisolone
(Synonym: Depo-medrol (TN))		[2] Mesalazine,
Methylprednisolone (Synonym: Depo-medrol With Lidocaine)		[7] D00377 ,
D00407 (Name: Medrol (TN)),
D00751 (Name: Solu-medrol (TN)),
D00979 (Name: Depo-medrol (TN)),
D05000 ,
D05001 ,
D05002 		[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 97
45Oral Methylprednisolone 625 mg/24h x3 days
(Synonym: Depo-medrol (TN))		[1] Methylprednisolone (Synonym: Depo-medrol With Lidocaine)[6] D00407 (Name: Medrol (TN)),
D00751 (Name: Solu-medrol (TN)),
D00979 (Name: Depo-medrol (TN)),
D05000 ,
D05001 ,
D05002 		[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 13
46Other: Exposure to methylprednisolone during pregnancy
(Synonym: Depo-medrol (TN))		[1] Methylprednisolone (Synonym: Depo-medrol With Lidocaine)[6] D00407 (Name: Medrol (TN)),
D00751 (Name: Solu-medrol (TN)),
D00979 (Name: Depo-medrol (TN)),
D05000 ,
D05001 ,
D05002 		[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 13
47Prednisone (and methylprednisolone)
(Synonym: Depo-medrol (TN))		[2] Methylprednisolone (Synonym: Depo-medrol With Lidocaine),
Prednisone		[7] D00407 (Name: Medrol (TN)),
D00473 ,
D00751 (Name: Solu-medrol (TN)),
D00979 (Name: Depo-medrol (TN)),
D05000 ,
D05001 ,
D05002 		[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 43
48Prednisone, methylprednisolone,cyclophosphamides
(Synonym: Depo-medrol (TN))		[2] Methylprednisolone (Synonym: Depo-medrol With Lidocaine),
Prednisone		[7] D00407 (Name: Medrol (TN)),
D00473 ,
D00751 (Name: Solu-medrol (TN)),
D00979 (Name: Depo-medrol (TN)),
D05000 ,
D05001 ,
D05002 		[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[3] 42, 43, 45
49SOLU MEDROL----[1] 56
50SOLU MEDROL - 125 MG/2 ML POLVERE E SOLVENTE PER SOLUZIONE INIETTABILE 1 FLACONE A DOPPIA CAMERA DA 125 MG/2 ML----[3] 13, 14, 53
51SOLU MEDROL - 40 MG/ML POLVERE E SOLVENTE PER SOLUZIONE INIETTABILE 1 FLACONE A DOPPIA CAMERA DA 40 MG/ML----[1] 56
52SOLU MEDROL - 500 MG/8 ML POLVERE E SOLVENTE PER SOLUZIONE INIETTABILE 1 FLACONE DI POLVERE DA 500 MG+ FIALA SOLVENTE DA 8 ML----[1] 56
53Solu-Medrol[1] Methylprednisolone hemisuccinate (Synonym: Solu-medrol Methylprednisolone Sodium Succinat)[1] D05000 [1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[7] 13, 49, 50, 51, 53, 97, 211
54Solu-medrol inj. PSO LQF 40mg[1] Methylprednisolone hemisuccinate (Synonym: Solu-medrol Methylprednisolone Sodium Succinat)[1] D05000 [1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 50
55Ursodeoxycholic acid+Low Dose Glucocorticoid(Methylprednisolone)
(Synonym: Depo-medrol (TN))		[2] Methylprednisolone (Synonym: Depo-medrol With Lidocaine),
Ursodeoxycholic acid		[7] D00407 (Name: Medrol (TN)),
D00734 ,
D00751 (Name: Solu-medrol (TN)),
D00979 (Name: Depo-medrol (TN)),
D05000 ,
D05001 ,
D05002 		[2] NR1H4,
NR3C1 💬		[2] Bile secretion, Neuroactive ligand-receptor interaction 💬[1] 93